Digital Health Platform Shae Significantly Reduces Type 2 Diabetes Risk in Comprehensive Study

Revolutionizing Diabetes Prevention: Is Shae the Digital Health Game Changer?

Digital health platform Shae demonstrates efficacy in reducing type 2 diabetes risk, according to a comprehensive retrospective analysis of nearly 1,700 users. The study, conducted over a four-year period, revealed significant improvements in key diabetes risk markers, with participants showing reductions in AUSDRISK scores and multiple anthropometric measures including BMI and waist-to-height ratio.

The analysis examined user data collected between 2014 and 2018, focusing on individuals who engaged with the platform for at least three months. Results showed that female participants, who comprised 87% of the study population, experienced a reduction in their AUSDRISK score from 8.95 to 7.87, while male participants saw their scores decrease from 10.82 to 9.79. Notably, women exhibited faster progress in anthropometric improvements and tended to remain engaged with the platform longer than men (11.7 months versus 10.3 months). The platform appears particularly effective at addressing central adiposity, with the waist-to-height ratio decreasing below the 0.51 diabetes risk threshold in both gender groups.

The Shae platform functions as both an assessment and intervention tool, creating a personalized "digital twin" based on users' anthropometric data and questionnaire responses. This model then generates tailored recommendations across multiple lifestyle domains including diet, physical activity, sleep hygiene, and psychological wellbeing. Currently available in over 140 countries, the platform is used by more than 2,000 health professionals and has been implemented in various settings including workplaces, schools, and fitness centers.

Key Finding: The Shae digital health platform demonstrated significant effectiveness in reducing type 2 diabetes risk across nearly 1,700 users over four years. Notable improvements included:
  • AUSDRISK scores decreased from 8.95 to 7.87 in women and 10.82 to 9.79 in men
  • BMI reduced from 26.74 to 25.23 kg/m² in women and 27.63 to 26.44 kg/m² in men
  • Waist-to-height ratio dropped below the 0.51 diabetes risk threshold in both genders
  • Body fat index showed substantial reductions: 37.36% to 32.72% (women) and 23.49% to 19.76% (men)
  • Decreased prevalence of hypertension and diabetes among participants

What Do Key Metrics Reveal About Lifestyle Interventions?

These findings contribute to a growing body of evidence regarding digital health interventions for chronic disease management. Previous research has yielded mixed results, with some studies indicating limited effectiveness of health applications while others suggest promising outcomes for diabetes management. This study adds weight to the latter, demonstrating that personalized digital platforms can effectively support lifestyle modifications that reduce diabetes risk factors.

The study authors note that their findings align with emerging research on gender-specific responses to lifestyle interventions. While women showed greater improvements in this analysis, previous meta-analyses have found similar efficacy between genders in reducing diabetes risk through lifestyle changes. The researchers suggest that women's higher engagement with the platform may partially explain the observed differences, noting that women generally access health-related apps more frequently than men, though typically engage less with content except for exercise-related materials.

Beyond AUSDRISK scores, the study demonstrated significant improvements in anthropometric measures across participants. BMI decreased from 26.74 to 25.23 kg/m² in women and from 27.63 to 26.44 kg/m² in men. Body fat index showed even more substantial reductions, decreasing from 37.36% to 32.72% in women and from 23.49% to 19.76% in men. These improvements in body composition metrics are particularly relevant given their established relationship with cardiometabolic risk and T2DM development.

The study also reported reductions in the prevalence of related health conditions among participants. The percentage of women with hypertension decreased from 11.4% to 7.9%, while men saw an even more dramatic reduction from 15.32% to 6.76%. Similarly, diabetes prevalence decreased from 13.3% to 8.79% in women and from 18.92% to 14.86% in men. These findings suggest that the platform's personalized approach to lifestyle modification may have broader health benefits beyond diabetes risk reduction.

Can We Overcome Limitations to Maximize Benefits?

Despite promising results, the study acknowledges several limitations, including reliance on self-reported measurements and the inability to control for participants' engagement with other health programs during the study period. The researchers recommend future studies examine the effectiveness of the Shae platform as an adjunct to behavioral lifestyle interventions rather than as a standalone solution.

The researchers conclude that mHealth platforms like Shae have significant potential to complement traditional interventions in diabetes prevention and management by delivering personalized, scalable, and accessible interventions that empower individuals to adopt healthier behaviors. They advocate for further optimization of such digital solutions to maximize public health impact.

Important: The platform creates a personalized "digital twin" based on user anthropometric data and questionnaire responses, generating tailored recommendations across multiple lifestyle domains including diet, physical activity, sleep hygiene, and psychological wellbeing. Female participants (87% of study population) showed greater improvements and longer engagement (11.7 months vs. 10.3 months for men). Currently available in over 140 countries and used by more than 2,000 health professionals, Shae represents a scalable, evidence-based approach to diabetes prevention, though researchers recommend using it as an adjunct to traditional behavioral interventions rather than a standalone solution.

What Impact Will Digital Health Have on Future Care?

Industry Context: This study emerges amid rapid expansion of the digital health sector, particularly solutions targeting chronic disease management. As healthcare systems worldwide grapple with the growing prevalence and economic burden of type 2 diabetes, digital platforms offering scalable, personalized interventions represent a promising approach to supplement traditional care models. The effectiveness demonstrated by Shae aligns with increasing investor interest in evidence-backed digital therapeutics that can demonstrate meaningful clinical outcomes while potentially reducing healthcare costs through prevention and improved self-management.

Summary

A comprehensive four-year retrospective analysis of nearly 1,700 users demonstrates that the digital health platform Shae effectively reduces type 2 diabetes risk through personalized lifestyle interventions. The study revealed significant improvements in key diabetes risk markers, with participants showing substantial reductions in AUSDRISK scores, BMI, body fat percentage, and waist-to-height ratio. Female participants, who comprised 87% of the study population, experienced particularly notable progress, with their AUSDRISK scores decreasing from 8.95 to 7.87, while maintaining longer platform engagement than male users. The platform functions by creating a personalized "digital twin" based on user data, generating tailored recommendations across diet, physical activity, sleep, and psychological wellbeing. Beyond diabetes risk reduction, the study documented decreased prevalence of hypertension and existing diabetes among participants. Currently available in over 140 countries and utilized by more than 2,000 health professionals, Shae represents a scalable approach to chronic disease prevention. While the study acknowledges limitations including reliance on self-reported measurements, the findings contribute valuable evidence supporting the role of personalized digital health platforms in complementing traditional diabetes prevention strategies and addressing the growing global burden of type 2 diabetes through accessible, evidence-based interventions.

PMCID
12594017